BTN2A1 and neoplasm: Finally, since BTN2A1 and BTN3A1 are not only expressed on tumor cells but also on Vg9Vd2 T cells and other T cells, the potential for (self-)elimination of immune cells should be taken into consideration when evaluating the safety profile and the presence of immune populations in peripheral blood (28).